期刊文献+

贝那普利、氨氯地平、卡维地洛对主动脉内皮细胞单层脂类通透性的影响 被引量:2

Effects of Benazepril,Amlodipine Besylate and Carvedilol on Permeability of Aortic Endothelial Cell Monolayers
下载PDF
导出
摘要 目的探讨血管紧张素转换酶抑制剂贝那普利、钙离子拮抗剂氨氯地平和β-受体阻滞剂卡维地洛对大鼠主动脉内皮细胞单层通透性的影响。方法分离培养大鼠主动脉内皮细胞(AEC):将AEC培养在混合纤维素酯微孔滤膜上,8 d后形成AEC单层进行通透性测定。将长有AEC的滤膜分别用上述三药处理4 h,置于灌注装置上,用含异硫氰酸荧光素标记白蛋白的高脂血灌注,测定收集液的量和白蛋白、总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)浓度。结果贝那普利、氨氯地平能够降低AEC单层对水、TC,TG,HDL,LDL的通透性(P<0.01);氨氯地平降低AEC单层对TC,LDL的通透性更为显著(P<0.001),卡维地洛作用不明显;只有氨氯地平能够降低AEC单层对白蛋白的通透性。结论贝那普利、氨氯地平可减少血浆中脂类渗入血管内皮下,具有潜在的抗动脉粥样硬化作用。 Objective To investigate the effects of angiotensin converting enzyme inhibitor benazepril, calcium channel blocker amlodipine besylate andβ-adrenoceptor agonist carvedilol on the permeability of rat aortic endothelial cell (AEC) monolayers. Methods The method of trauma - free isolation was adopted in the culture of rat AECs. Rat AECs were seeded on the nitrocellulose microporous filters. After an eight days" seeding, the monolayers could be used for measuring the permeability. Before being perfused, monolayers were treated with Benazepril, Amlodipine and Carvedilol for four hours successively. The prepared filters were mounted on the Boydon chambers and perfused with hyperlipemia containing fluorescein isothiocyanate ( FITC ) -labeled albumin. The fluid filtering through the monolayers and the filter was collected and the albumin concentration was measured. At the same time, the concentrations of cholesterol, triglyceride (TG) , high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in the collected fluid were also measure by ELISA. Results Benazepril and Amlodipine decreased the permeability of the confluent AEC monolayers to water, cholesterol, TG, HDL and LDL significantly (P 〈 0.01 ). Amlodipine had more significant effects than the former two drugs. Carvedilol had no obvious effect. Conclusion Benazepril and Amlodipine may decrease the infiltration of lipids and lipoproteins into the subendothelial space, and can be thus used to prevent and ameliorate atherosclerosis.
出处 《临床军医杂志》 CAS 2006年第2期133-135,共3页 Clinical Journal of Medical Officers
关键词 血管内皮细胞单层 通透性 血脂 贝那普利 氨氯地平 卡维地洛 endothelium capillary permeability fipoprotein benazepril amlodipine carvedilol
  • 相关文献

参考文献3

二级参考文献6

  • 1[1] Weidmann P,Ferrier C,Saxenhofer H,et al.Serum lipoproteins during treatment with antihypertensive drugs[J].Drugs,1988,35 Suppl 6:118
  • 2[2] Leren P.Lipid effects of antihypertensive drugs[J].Clin Exp Hypertens A,1990,12(5):761
  • 3[3] McTavish D,Campoi-Richards D,Sorkin EM.Carvedilol,a review of its pharmacodynamic and pharmacokinetic properties,and therapeutic efficacy[J].Drugs,1993,45(2):232
  • 4[4] Goto-Y,Tamachi-H,Fusegawa-Y,Nakaya-N,et al.Effects of carvedilol on serum lipids in patients with essential hypertension[J].J Cardiovasc Pharmacol,1991,18(Suppl 4):S45
  • 5[5] Tadepalli AS,Novak PJ.Intrinsic sympathomimetic activity of labetalol[J].J Cardiovasc Pharmacol,1986,8(1):44
  • 6朱文青.2002年肾上腺素能阻滞剂在心血管病中的临床应用国际研讨会简介[J].中华心血管病杂志,2002,30(7):439-439. 被引量:36

共引文献20

同被引文献29

  • 1张石革,陈瑞红,梁建华.二氢吡啶类钙通道阻滞剂控制血压的临床评价[J].中国医院用药评价与分析,2004,4(4):202-206. 被引量:8
  • 2刘海宁,张兴华,耿庆信.拉西地平、氨氯地平对人脐静脉内皮细胞间粘附分子1表达的影响[J].中国动脉硬化杂志,2005,13(5):575-578. 被引量:7
  • 3张新军.解析ARB/利尿剂联合治疗的价值.中国医学论坛报,2010,36(26):10-10.
  • 4Turgan N, Habif S, Kabaroglu CG, et al. Effects of the cslcium channel blocker amlodipine on serum and aortic cholesterol, lipid peroxidation, antioxidant status and aortic histology in choleste-rol-fed rabbits [J]. J Biomed Sci, 2003, 10 (1): 65-72.
  • 5Akira K, Amano M, Okajima F, et al. Inhibitory, effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits [J]. Biol Pharm Bull. 2006, 29 (1) : 75-81.
  • 6Yoshii T, Iwai M, Li Z, et al. Regreasion of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions [J]. Hypertens Res, 2006, 29 (6): 457-466.
  • 7van de Poll SW, Delsing DJ, Wouter Jukema J, et al. Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in AFOE * 3-Leidon transgenic mice [J]. J Mol Cell Cardiol, 2003, 35(1): 109- 118.
  • 8Candido R, Allen TJ, Laesila M, et al. Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis [J]. Circulation, 2004, 109 (12): 1 536-542.
  • 9Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on Cardiovascular eventsin patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controned trial [J]. JAMA,2004, 292(18): 2 217-225.
  • 10Brener SJ, Ivanc TB, Poliazczuk R, et al. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials [J]. Am Heart J, 2006, 152 (6) : 1 059-063.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部